By John Rogers

Four major U.S. hospital systems — led by Utah’s Intermountain Healthcare — are planning to launch a nonprofit company to produce generic drugs in what the organization characterizes as a bid to fix a situation where soaring prices and drug shortages have hampered medical care. The nonprofit systems said the new firm will seek Food and Drug Administration approval to manufacture and market generic drugs or, alternatively, buy FDA approvals from other companies. Actual drug manufacturing will likely come from existing drug companies, according to a release from the hospital chains issued through Intermountain.

The rest of this article is only available to our online subscribers. Please log in, or click here to subscribe.

Pin It